USA President Donald Trump said that Eli Lilly has invested $27 billion, and Novo Nordisk is investing $10 billion in the United States, funding the construction of new manufacturing facilities. He also added that his scale of investment is unprecedented in the country’s history.

LONDON (Reuters) -Boardroom drama at Wegovy-maker Novo Nordisk has laid bare the company's biggest challenge: how to better tap into America's mass market for weight-loss drugs. The Danish drugmaker that initially soared on the success of its obesity drug ...